Pharmaceutical Analysis & Statistics, July 2014 (p100)

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

2971-3010 of about 28 000 reports

Purchase Reports From Reputable Market Research Publishers

PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

PPAR-Beta / Delta Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PPAR-Beta / Delta Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

Progesterone Receptor (PR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor (PR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug and Medication
Progesterone Receptor Agonists -Pipeline Insights, 2014

Progesterone Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Progesterone Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug and Medication
Prolactin Receptor Antagonists -Pipeline Insights, 2014

Prolactin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prolactin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Prostaglandin Antagonists -Pipeline Insights, 2014

Prostaglandin Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin E2 (PGE2) Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug Discovery and Development
Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Prostaglandin F2-Alpha Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

Purine Nucleoside Phosphorylase (PNPase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purine Nucleoside Phosphorylase (PNPase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

Purinergic Receptor (Purinoceptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Purinergic Receptor (Purinoceptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Pyrimidine Analogues -Pipeline Insights, 2014

Pyrimidine Analogues -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Pyrimidine Analogues-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
R2 Subunit Of Ribonucleotide Reductase Inhibitors -Pipeline Insights, 2014

R2 Subunit Of Ribonucleotide Reductase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“R2 Subunit Of Ribonucleotide Reductase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Raf/MEK/ERK Signaling Cascade Inhibitirs -Pipeline Insights, 2014

Raf/MEK/ERK Signaling Cascade Inhibitirs -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Raf/MEK/ERK Signaling Cascade Inhibitirs-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Receptor For Advanced Glycation End Product (RAGE) Inhibitors -Pipeline Insights, 2014

Receptor For Advanced Glycation End Product (RAGE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Receptor For Advanced Glycation End Product (RAGE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Renin Inhibitors -Pipeline Insights, 2014

Renin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Renin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Alpha (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Alpha (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Alpha (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Beta  (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Beta (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Beta (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoic Acid Receptors Gamma (RARs) Agonists -Pipeline Insights, 2014

Retinoic Acid Receptors Gamma (RARs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoic Acid Receptors Gamma (RARs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Retinoid x receptors (RXRs) Agonists -Pipeline Insights, 2014

Retinoid x receptors (RXRs) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Retinoid x receptors (RXRs) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Reversible Anticholinesterases -Pipeline Insights, 2014

Reversible Anticholinesterases -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Reversible Anticholinesterases-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Ribosome Inhibitors -Pipeline Insights, 2014

Ribosome Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ribosome Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Sclerostin Inhibitors -Pipeline Insights, 2014

Sclerostin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Sclerostin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Secretase inhibitors -Pipeline Insights, 2014

Secretase inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Secretase inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Selectin Inhibitors -Pipeline Insights, 2014

Selectin Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selectin Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Selective COX Inhibitors -Pipeline Insights, 2014

Selective COX Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective COX Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Selective COX-2 Inhibitors -Pipeline Insights, 2014

Selective COX-2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Selective COX-2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
About 55 000 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Market in the US

  • Grand Rounds
  • September 2014
    4 pages
  • Drug And Medica...  

    Drug  

  • United States  

View report >

About 600 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.